Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,541 to 1,560 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| [Clinical features and prognosis of core binding factor acute myeloid leukemia in children]. | Zhongguo Dang Dai Er Ke Za Zhi | 2020 | 32669171 | PubTator, text mining | PubMed |
| [Clinical analysis in five patients with acute leukemia and HIV infection]. | Zhonghua Xue Ye Xue Za Zhi | 2020 | 32654469 | PubTator, text mining | PubMed |
| CHEDDA syndrome: a case report and review of the literature for this newly described entity. | Radiol Case Rep | 2020 | 32642015 | PubTator, text mining | PubMed |
| Overexpression of annexin A5 might guide the gemtuzumab ozogamicin treatment choice in patients with pediatric acute myeloid leukemia. | Ther Adv Med Oncol | 2020 | 32636939 | PubTator, text mining | PubMed |
| Identification of miRNA Master Regulators in Breast Cancer. | Cells | 2020 | 32635183 | PubTator, text mining | PubMed |
| Epigenetic Regulation of Gfi1 in Endocrine-Related Cancers: a Role Regulating Tumor Growth. | Int J Mol Sci | 2020 | 32630147 | PubTator, text mining | PubMed |
| Digital Droplet PCR is a Specific and Sensitive Tool for Detecting IDH2 Mutations in Acute Myeloid LeuKemia Patients. | Cancers (Basel) | 2020 | 32629801 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia in Qatar (2010-2016): Clinical, Biological, and Prognostic Factors and Treatment Outcomes. | Front Genet | 2020 | 32625233 | PubTator, text mining | PubMed |
| Targeting nuclear import and export in hematological malignancies. | Leukemia | 2020 | 32624581 | PubTator, text mining | PubMed |
| Valproic acid promotes mitochondrial dysfunction in primary human hepatocytes in vitro; impact of C/EBPα-controlled gene expression. | Arch Toxicol | 2020 | 32623605 | PubTator, text mining | PubMed |
| Clinical utility of target capture-based panel sequencing in hematological malignancies: A multicenter feasibility study. | Cancer Sci | 2020 | 32619037 | PubTator, text mining | PubMed |
| The expression and regulation of HOX genes and membrane proteins among different cytogenetic groups of acute myeloid leukemia. | Mol Genet Genomic Med | 2020 | 32614525 | PubTator, text mining | PubMed |
| Isolated Intracranial Myeloid Sarcoma Mimicking Malignant Lymphoma: A Diagnostic Challenge and Literature Reviews. | Onco Targets Ther | 2020 | 32612369 | PubTator, text mining | PubMed |
| Poor Prognosis Biomolecular Factors Are Highly Frequent in Childhood Acute Leukemias From Oaxaca, Mexico. | Technol Cancer Res Treat | 2020 | 32608319 | PubTator, text mining | PubMed |
| HSPG2 overexpression independently predicts poor survival in patients with acute myeloid leukemia. | Cell Death Dis | 2020 | 32606327 | PubTator, text mining | PubMed |
| Identification and functional characterization of a novel surfactant protein A2 mutation (p.N207Y) in a Chinese family with idiopathic pulmonary fibrosis. | Mol Genet Genomic Med | 2020 | 32602668 | PubTator, text mining | PubMed |
| Differences between Well-Differentiated Neuroendocrine Tumors and Ductal Adenocarcinomas of the Pancreas Assessed by Multi-Omics Profiling. | Int J Mol Sci | 2020 | 32586046 | PubTator, text mining | PubMed |
| Impact of HDAC Inhibitors on Protein Quality Control Systems: Consequences for Precision Medicine in Malignant Disease. | Front Cell Dev Biol | 2020 | 32582706 | PubTator, text mining | PubMed |
| Comprehensive Analysis of Key Genes and Regulatory Elements in Osteosarcoma Affected by Bone Matrix Mineral With Prognostic Values. | Front Genet | 2020 | 32582282 | PubTator, text mining | PubMed |
| Molecular Targeting and Rational Chemotherapy in Acute Myeloid Leukemia. | J Exp Pharmacol | 2020 | 32581600 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=78